Samsung to Invest $740 Million in New Drug Facility

Samsung BioLogics said it would construct a new facility in South Korea that will double its production capacity and make it the world’s largest contract drug maker.

from WSJ.com: US Business http://ift.tt/1PRZPm1
via IFTTT